Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli - PubMed (original) (raw)
. 2002 May 15;99(10):3838-43.
doi: 10.1182/blood.v99.10.3838.
Affiliations
- PMID: 11986244
- DOI: 10.1182/blood.v99.10.3838
Free article
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
Massimo Di Nicola et al. Blood. 2002.
Free article
Abstract
CD2(+) T lymphocytes obtained from either the donor of bone marrow stromal cells (BMSCs) or a third party were cultured in mixed lymphocyte reactions (MLRs) with either allogeneic dendritic cells (DCs) or peripheral blood lymphocytes (PBLs). When autologous or allogeneic BMSCs were added back to T cells stimulated by DCs or PBLs, a significant and dose-dependent reduction of T-cell proliferation, ranging from 60% +/- 5% to 98% +/- 1%, was evident. Similarly, addition of BMSCs to T cells stimulated by polyclonal activators resulted in a 65% +/- 5% (P =.0001) suppression of proliferation. BMSC- induced T-cell suppression was still evident when BMSCs were added in culture as late as 5 days after starting of MLRs. BMSC-inhibited T lymphocytes were not apoptotic and efficiently proliferated on restimulation. BMSCs significantly suppressed both CD4(+) and CD8(+) T cells (65% +/- 5%, [P =.0005] and 75% +/- 15% [P =.0005], respectively). Transwell experiments, in which cell-cell contact between BMSCs and effector cells was prevented, resulted in a significant inhibition of T-lymphocyte proliferation, suggesting that soluble factors were involved in this phenomenon. By using neutralizing monoclonal antibodies, transforming growth factor beta1 and hepatocyte growth factor were identified as the mediators of BMSC effects. In conclusion, our data demonstrate that (1) autologous or allogeneic BMSCs strongly suppress T-lymphocyte proliferation, (2) this phenomenon that is triggered by both cellular as well as nonspecific mitogenic stimuli has no immunologic restriction, and (3) T-cell inhibition is not due to induction of apoptosis and is likely due to the production of soluble factors.
Similar articles
- Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Tse WT, et al. Transplantation. 2003 Feb 15;75(3):389-97. doi: 10.1097/01.TP.0000045055.63901.A9. Transplantation. 2003. PMID: 12589164 - Comparison of human bone marrow stromal cells cultured in human platelet growth factors and fetal bovine serum.
Ren J, Ward D, Chen S, Tran K, Jin P, Sabatino M, Robey PG, Stroncek DF. Ren J, et al. J Transl Med. 2018 Mar 14;16(1):65. doi: 10.1186/s12967-018-1400-3. J Transl Med. 2018. PMID: 29540180 Free PMC article. - Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.
Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Le Blanc K, et al. Scand J Immunol. 2003 Jan;57(1):11-20. doi: 10.1046/j.1365-3083.2003.01176.x. Scand J Immunol. 2003. PMID: 12542793 - Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitro.
Kiernan CH, Hoogduijn MJ, Franquesa M, Wolvius EB, Brama PAJ, Farrell E. Kiernan CH, et al. Cytotherapy. 2016 Aug;18(8):957-969. doi: 10.1016/j.jcyt.2016.05.002. Epub 2016 Jun 7. Cytotherapy. 2016. PMID: 27288309
Cited by
- Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.
Mansilla MJ, Presas-Rodríguez S, Teniente-Serra A, González-Larreategui I, Quirant-Sánchez B, Fondelli F, Djedovic N, Iwaszkiewicz-Grześ D, Chwojnicki K, Miljković Đ, Trzonkowski P, Ramo-Tello C, Martínez-Cáceres EM. Mansilla MJ, et al. Cell Mol Immunol. 2021 Jun;18(6):1353-1374. doi: 10.1038/s41423-020-00618-z. Epub 2021 May 6. Cell Mol Immunol. 2021. PMID: 33958746 Free PMC article. Review. - Transplanted Antler Stem Cells Stimulated Regenerative Healing of Radiation-induced Cutaneous Wounds in Rats.
Rong X, Zhang G, Yang Y, Gao C, Chu W, Sun H, Wang Y, Li C. Rong X, et al. Cell Transplant. 2020 Jan-Dec;29:963689720951549. doi: 10.1177/0963689720951549. Cell Transplant. 2020. PMID: 32907381 Free PMC article. - Mesenchymal Stromal Cell-Based Therapy-An Alternative to Arthroplasty for the Treatment of Osteoarthritis? A State of the Art Review of Clinical Trials.
Maleitzke T, Elazaly H, Festbaum C, Eder C, Karczewski D, Perka C, Duda GN, Winkler T. Maleitzke T, et al. J Clin Med. 2020 Jun 30;9(7):2062. doi: 10.3390/jcm9072062. J Clin Med. 2020. PMID: 32630066 Free PMC article. Review. - Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S, Abdelalim EM. Al-Khawaga S, et al. Stem Cell Res Ther. 2020 Oct 15;11(1):437. doi: 10.1186/s13287-020-01963-6. Stem Cell Res Ther. 2020. PMID: 33059757 Free PMC article. Review. - Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth.
Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, Shang X, Zhang ZG, Chopp M. Xin H, et al. Stem Cells. 2012 Jul;30(7):1556-64. doi: 10.1002/stem.1129. Stem Cells. 2012. PMID: 22605481 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials